Features

Six OHSU faculty members certified in new clinical informatics specialty

We’re re-posting the following from the School of Medicine News. The School of Medicine has six faculty members who are now certified in the brand new medical subspecialty of clinical informatics. The intersection of health care reform and information technology advances are driving the establishment of this new clinical subspeciality. “The new subspecialty is a recognition of the importance that data and information play in health care,” said William Hersh, M.D., professor and chair of … Read More

Top 10 Research News posts from 2013

Here’s a brief summary of our most popular blog posts published in 2013 according to Google Analytics. Thanks for reading and have a Happy Year New! Update regarding federal government shutdown Inventive OHSU postdoc “traps” scientific creativity to solve problems Dr. Mitalipov’s stem cell discovery named a Top 10 Breakthrough of 2013 Novo Nordisk Diabetes and Obesity Award; applications due May 1 Tartar Trust Fellowships, applications due April 19 OHSU vaccine candidate completely clears AIDS-causing … Read More

OHSU, Portland State, and Portland Development Commission partner on grants to startups

Earlier this year, the Portland Development Commission launched the University Startup Commercialization Grant Program to strengthen the relationship between Portland’s two major research universities—OHSU and Portland State—and the city’s entrepreneurs. As a result, six local startup companies based on OHSU and PSU technologies will receive grants of up to $30,000 to support commercialization. The three OHSU-affiliated recipients are: Nzumbe, Odyssey Science Innovations and Gamma Therapeutics. The three PSU-affiliated recipients are: SweetSense, Inc., APDM and Hawthorne … Read More

Dr. Mitalipov’s stem cell discovery named a Top 10 Breakthrough of 2013

As we wrap up 2013, several publications have issued Top 10 lists for 2013. Shoukhrat Mitalipov, Ph.D., a senior scientist at the Oregon National Primate Research Center, has been recognized by four national publications —Time, Nature, Science, and Discover—for being the first person to transform human skin cells into embryonic stem cells using a technique called somatic cell nuclear transfer. The discovery holds promise for treating conditions such as Parkinson’s disease, multiple sclerosis, cardiac disease and spinal cord injuries.

OHSU faculty members Bradley Tebo, Ph.D., and Caroline Enns, Ph.D., named AAAS Fellows

Two OHSU faculty members, Bradley Tebo, Ph.D., and Caroline Enns, Ph.D., have been elected Fellows of the American Association for the Advancement of Science (AAAS). Drs. Tebo and Enns are among 388 newly-elected Fellows who were recognized by their peers for their efforts to advance science or its applications. Dr. Tebo, associate director and professor at OHSU’s Institute of Environmental Health and head of the Division of Enrionmental and Biomolecular Systems, was elected as an … Read More

OHSU publication selected for the Journal of Biological Chemistry’s “Paper of the Week”

A publication by Pei-Chun Chen, Ph.D., postdoctoral fellow in the Department of Biochemistry and Molecular Biology, and her mentor, Show-Ling Shyng, Ph.D., has been selected as a “Paper of the Week” by the Journal of Biological Chemistry. The paper, “Leptin Regulates KATP Channel Trafficking in Pancreatic β-cells by a Signaling Mechanism Involving AMPK and PKA,” was highlighted online and in the Nov. 22 print version of the journal. Additionally, a figure from the paper was selected for … Read More

Gearing up for the eCRIS transition in 2014

In about two months, eCRIS, OHSU’s new clinical research management system, will be required for all new clinical studies enrolling prospectively consented human subjects. Later in 2014, eCRIS will become mandatory for existing studies as well. As of October, about 100 people have been trained on eCRIS and 60 new studies have voluntarily made the transition. While eCRIS was designed to make your life easier, new users have found that it’s harder to learn when … Read More

Reminder: Biomedical Innovation Program Panel Discussion on Nov. 11

Innovation Panel Discussion being held November 11. 2013, from 3 to 4 p.m. in CHH 3171. Please RSVP to Colleen Lay if you would like to attend the panel discussion. The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The intent of this funding mechanism is to accelerate the delivery of healthcare technologies from academia to the marketplace, thereby improving health care. All applicants are strongly … Read More

Information for federal grant submission post-shutdown

This following message was sent to all OHSU faculty, postdoctoral fellows, research-ranked employees, department administrators, and RDA personnel on Monday, October 21, 2013. Dear colleagues, This is to update you regarding our OHSU process for federal grants submission as the government resumes operations post-shutdown. The NIH and other federal organizations have adjusted deadlines to accommodate for the shutdown, and this will have several impacts on anyone submitting in October and November. These processes are designed … Read More

Winter deadlines for American Heart research grants and fellowships

The American Heart Association has announced its winter deadlines for a wide range of funding opportunities relating to cardiovascular disease and stroke. All proposals and applications will be due either January 16th or 17th, 2014. Find the full program descriptions below. American Heart Association – Winter 2014 Funding Opportunities National Scientist Development Grant- Up to $77,000 per year for up to four years to support beginning scientists in their progress toward independence by funding research projects … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives